These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3650100)

  • 21. Sequential changes in antibody levels to the env and gag antigens in human immunodeficiency virus infected subjects.
    Manca N; di Marzo Veronese F; Ho DD; Gallo RC; Sarngadharan MG
    Eur J Epidemiol; 1987 Jun; 3(2):96-102. PubMed ID: 3497054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Site-directed ELISA with synthetic peptides representing the HIV transmembrane glycoprotein.
    Chiodi F; von Gegerfeldt A; Albert J; Fenyö EM; Gaines H; von Sydow M; Biberfeld G; Parks E; Norrby E
    J Med Virol; 1987 Sep; 23(1):1-9. PubMed ID: 3500271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Densitometric analysis of Western blot (immunoblot) assays for human immunodeficiency virus antibodies and correlation with clinical status.
    Schmidt G; Amiraian K; Frey H; Stevens RW; Berns DS
    J Clin Microbiol; 1987 Oct; 25(10):1993-8. PubMed ID: 2444624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutralizing antibodies against two HIV-1 strains in consecutively collected serum samples: cross neutralization and association to HIV-1 related disease.
    Arendrup M; Nielsen CM; Hansen JE; Mathiesen LR; Lindhardt BO; Scheibel E; Nielsen JO
    Scand J Infect Dis; 1992; 24(1):21-8. PubMed ID: 1589722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas.
    Carrow EW; Vujcic LK; Glass WL; Seamon KB; Rastogi SC; Hendry RM; Boulos R; Nzila N; Quinnan GV
    AIDS Res Hum Retroviruses; 1991 Oct; 7(10):831-8. PubMed ID: 1720630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of serum antibodies to reverse transcriptase in HIV-1-infected individuals.
    DeVico AL; Veronese FD; Lee SL; Gallo RC; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1988 Feb; 4(1):17-22. PubMed ID: 2452648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies.
    Nara PL; Robey WG; Pyle SW; Hatch WC; Dunlop NM; Bess JW; Kelliher JC; Arthur LO; Fischinger PJ
    J Virol; 1988 Aug; 62(8):2622-8. PubMed ID: 3392769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virus neutralizing antibodies at different stages of the HIV disease: increased levels after azidothymidine treatment.
    Schmidtmayerová H; Lackovicová M; Stanková M; Brůcková M; Surový I; Ujhelyi E; Füst G; Mayer V
    Acta Virol; 1992 Mar; 36(2):157-65. PubMed ID: 1359767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro generation of an HTLV-III variant by neutralizing antibody.
    Robert-Guroff M; Reitz MS; Robey WG; Gallo RC
    J Immunol; 1986 Nov; 137(10):3306-9. PubMed ID: 3639908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serologic characterization of human immunodeficiency virus infection by Western blot and radioimmunoprecipitation assays.
    Resnick L; Shapshak P
    Arch Pathol Lab Med; 1987 Nov; 111(11):1040-4. PubMed ID: 3478005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of enzyme-linked immunosorbent assays for serum human immunodeficiency virus antigen and antibodies to recombinant viral proteins with subsequent clinical outcomes in a cohort of asymptomatic homosexual men.
    Mayer KH; Falk LA; Paul DA; Dawson GJ; Stoddard AM; McCusker J; Saltzman SP; Moon MW; Ferriani R; Groopman JE
    Am J Med; 1987 Aug; 83(2):208-12. PubMed ID: 3650022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new ELISA test for HIV antibodies using a bacterially produced viral env gene product.
    Schneider J; Wendler I; Guillot F; Hunsmann G; Gallati H; Schoenfeld HJ; Stüber D; Mous J
    Med Microbiol Immunol; 1987; 176(1):47-51. PubMed ID: 3547057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential neutralizing capacity to different human immunodeficiency virus (HIV) isolates by a rabbit antiserum against LAV: sensitive assays with HTLV-I-positive MT-4 cells.
    Yoshiyama H; Nakashima H; Kobayashi S; Yamamoto N
    AIDS Res Hum Retroviruses; 1988 Apr; 4(2):91-8. PubMed ID: 3284555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infection.
    Smith RS; Naso RB; Rosen J; Whalley A; Hom YL; Hoey K; Kennedy CJ; McCutchan JA; Spector SA; Richman DD
    J Clin Microbiol; 1987 Aug; 25(8):1498-504. PubMed ID: 3476491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein.
    Matthews TJ; Langlois AJ; Robey WG; Chang NT; Gallo RC; Fischinger PJ; Bolognesi DP
    Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9709-13. PubMed ID: 2432599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibody identifies a highly conserved and immunodominant epitope of the human immunodeficiency virus transmembrane protein.
    Papsidero LD; Poiesz BJ; Montagna RA
    Hybridoma; 1988 Apr; 7(2):117-28. PubMed ID: 2453451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for an antiviral effect and interferon neutralizing capacity in human sera; variability and implications for HIV infection.
    Fall LS; Chams V; Le Coq H; Fouchard M; M'Bika JP; Gringeri A; Santagostino E; Bizzini B
    Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):409-16. PubMed ID: 7580835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection and characterization of circulating immune complexes in HIV-related diseases.
    Carini C; D'Amelio R; Mezzaroma I; Aiuti F
    Diagn Clin Immunol; 1987; 5(3):135-9. PubMed ID: 3480082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of gp41 antigens by enzyme-linked immunosorbent assays for detecting antibodies to human immunodeficiency virus type 1.
    Zweig M; Bladen SV; Dubois GC; Samuel KP; Showalter SD; Papas TS
    AIDS Res Hum Retroviruses; 1988 Dec; 4(6):487-92. PubMed ID: 3265329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum IgG and IgA antibodies specific to Epstein-Barr virus capsid antigen in a longitudinal study of human immunodeficiency virus infection and disease progression in homosexual men.
    Margalith M; Sarov B; Sarov I; Rinaldo C; Detels R; Phair J; Kaslow R; Ginsberg H; Saah A
    AIDS Res Hum Retroviruses; 1990 May; 6(5):607-16. PubMed ID: 2193673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.